Stephane Epelbaum
Stephane Epelbaum
Praticien Hospitalier, Pitié Salpêtrière University Hospital
Verified email at aphp.fr
Title
Cited by
Cited by
Year
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ...
The Lancet Neurology 13 (6), 614-629, 2014
24322014
Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria
B Dubois, H Hampel, HH Feldman, P Scheltens, P Aisen, S Andrieu, ...
Alzheimer's & Dementia 12 (3), 292-323, 2016
9132016
Pure alexia as a disconnection syndrome: new diffusion imaging evidence for an old concept
S Epelbaum, P Pinel, R Gaillard, C Delmaire, M Perrin, S Dupont, ...
cortex 44 (8), 962-974, 2008
2732008
APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases
HM Lanoiselée, G Nicolas, D Wallon, A Rovelet-Lecrux, M Lacour, ...
PLoS medicine 14 (3), e1002270, 2017
2032017
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World …
P Lewczuk, P Riederer, SE O’Bryant, MM Verbeek, B Dubois, PJ Visser, ...
The world journal of biological psychiatry 19 (4), 244-328, 2018
1322018
Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study
B Dubois, S Epelbaum, F Nyasse, H Bakardjian, G Gagliardi, ...
The Lancet Neurology 17 (4), 335-346, 2018
1142018
Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020
H Hampel, S Lista, SJ Teipel, F Garaci, R Nistico, K Blennow, ...
Biochemical pharmacology 88 (4), 426-449, 2014
1142014
Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia
RER Slot, SAM Sikkes, J Berkhof, H Brodaty, R Buckley, E Cavedo, ...
Alzheimer's & Dementia 15 (3), 465-476, 2019
1092019
Detection of volume loss in hippocampal layers in Alzheimer's disease using 7 T MRI: a feasibility study
C Boutet, M Chupin, S Lehéricy, L Marrakchi-Kacem, S Epelbaum, ...
NeuroImage: Clinical 5, 341-348, 2014
832014
Alzheimer's disease biomarker‐guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1–42, total‐tau …
H Hampel, N Toschi, F Baldacci, H Zetterberg, K Blennow, I Kilimann, ...
Alzheimer's & Dementia 14 (4), 492-501, 2018
672018
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease
A Vergallo, L Mégret, S Lista, E Cavedo, H Zetterberg, K Blennow, ...
Alzheimer's & Dementia 15 (6), 764-775, 2019
612019
Preclinical Alzheimer's disease: a systematic review of the cohorts underlying the concept
S Epelbaum, R Genthon, E Cavedo, MO Habert, F Lamari, G Gagliardi, ...
Alzheimer's & Dementia 13 (4), 454-467, 2017
562017
Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease
S Lista, N Toschi, F Baldacci, H Zetterberg, K Blennow, I Kilimann, ...
Neurochemistry international 108, 355-360, 2017
432017
17q21. 31 duplication causes prominent tau-related dementia with increased MAPT expression
K Le Guennec, O Quenez, G Nicolas, D Wallon, S Rousseau, AC Richard, ...
Molecular psychiatry 22 (8), 1119-1125, 2017
432017
Symptomatic and proven de novo amyloid polyneuropathy in familial amyloid polyneuropathy domino liver recipients
D Adams, C Lacroix, T Antonini, P Lozeron, C Denier, AM Kreib, ...
Amyloid 18 (sup1), 174-177, 2011
432011
Free and Cued Selective Reminding Test–accuracy for the differential diagnosis of Alzheimer's and neurodegenerative diseases: a large-scale biomarker-characterized monocenter …
M Teichmann, S Epelbaum, D Samri, ML Nogueira, A Michon, H Hampel, ...
Alzheimer's & Dementia 13 (8), 913-923, 2017
422017
Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints
E Cavedo, PA Chiesa, M Houot, MT Ferretti, MJ Grothe, SJ Teipel, S Lista, ...
Alzheimer's & Dementia 14 (9), 1204-1215, 2018
412018
Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease
F Baldacci, N Toschi, S Lista, H Zetterberg, K Blennow, I Kilimann, ...
Alzheimer's & Dementia 13 (9), 993-1003, 2017
412017
EEG evidence of compensatory mechanisms in preclinical Alzheimer’s disease
S Gaubert, F Raimondo, M Houot, MC Corsi, L Naccache, J Diego Sitt, ...
Brain 142 (7), 2096-2112, 2019
392019
Verbal memory impairment in subcortical ischemic vascular disease: a descriptive analysis in CADASIL
S Epelbaum, S Benisty, S Reyes, M O'Sullivan, E Jouvent, M Düring, ...
Neurobiology of aging 32 (12), 2172-2182, 2011
392011
The system can't perform the operation now. Try again later.
Articles 1–20